NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

New Year's resolutions often focus on improving fitness and health, particularly after the excesses of the holiday season. However, keeping up the momentum for weight loss and exercise can be ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

In obesity, it will compete with Novo Nordisk’s GLP-1 agonist Wegovy (semaglutide), which ... available in the original singe-dose pen-injector format. Mounjaro has already been launched in ...

New Year's resolutions often focus on improving health and fitness, particularly after the festive season's indulgence. However, keeping up the motivation for weight loss and fitness can be a ...

New Year's resolutions often centre around health and fitness, particularly after the festive season's indulgence. However, keeping up the momentum for weight loss and fitness can be a struggle ...

The body, which represents independent community pharmacies, argues a two-way consultation with the patient lasting at least 20 minutes is needed rather than relying on online questionnaires to access ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...